Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-07

Clinical Trial Update: The Effect of Intranasal Oxytocin on Emphatic Abilities in Patients With Post Traumatic Stress Disorder (PTSD) [Phase 4]

View source ↗

Summary

This update reports a Phase 4 trial evaluating intranasal oxytocin for empathic abilities in patients with post-traumatic stress disorder. The study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (intranasal) (oxytocin)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Post Traumatic Stress Disorder | Phase 4 | Status: COMPLETED